AKLI240517P500
- 0.06
- 0.000.00%
Akili Newsroom
Akili Q1 2024 Adj EPS $(0.12) Beats $(0.14) Estimate, Sales $383.00K Miss $794.00K Estimate
Akili (NASDAQ:AKLI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 29.41 percent increase over losses of $(0.17) per sh
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersArcutis Biotherapeutics (NASDAQ:ARQT) stock moved upwards by 16.4% to $9.46 during Tuesday's after-market session. The company's market cap stands at $1.0 billion. As per the press release, Q1
Express News | Akili Evaluates Potential Strategic Alternatives
Akili | 10-Q: Quarterly report
Akili 1Q Rev $383,000 >AKLI
Akili 1Q Rev $383,000 >AKLI
Earnings Flash (AKLI) AKILI Posts Q1 Revenue $383,000, Vs. Street Est of $0.8M
04:03 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (AKLI) AKILI Posts Q1 Revenue $383,000, vs. Street Est of $0.8M
Express News | Akili Inc: Will Not Provide Financial Guidance Until Further Notice
Express News | Akili Inc: Evaluating Potential Strategic Alternatives
Express News | Akili Inc: Full Voluntary Prepayment of Debt and Termination of Amended & Restated Loan and Security Agreement With Silicon Valley Bank
Express News | Akili Reports First Quarter 2024 Financial Results and Provides Business Update
Trending Stocks Today: Akili Surges 70.92%
April 30th - US stocks trending in regular trading hours.Gainers: $Akili(AKLI.US)$ surges 70.92% to $0.4 with a turnover of $33.74 million. $Global Mofy Metaverse(GMM.US)$ soars 53.71% to $1.43 with a
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of H&E Equipment Services, Inc. (NASDAQ:HEES) fell sharply during Tuesday's session following mixed first-quarter results.H&E Equipment posted GAAP earnings of 71 cents per share, versus market
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersAkili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday's regular session. The company's market cap stands at $31.4 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock rose 51
Express News | Akili Shares Are Trading Higher After the Company Announced Shionogi Has Canceled and Forgiven a $5.0 Million Long-term Debt Obligation and Agreed to Make Certain Payments for SDT-001
Express News | Akili Plans To Continue to Pursue Marketing Authorization From FDA Of EndeavorOTC Product
Express News | Trading Halt: Halt Status Updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Akili Announces Company's Workforce Will Be Reduced By ~46% Including An Elimination Of The Company's Marketing And Medical Affairs Teams
Express News | Akili Inc - Sees Severance,Restructuring-Related Costs to Be About $2.3 – $2.8 Mln, Expects to Record Charges in Q2 2024
Akili Bd of Directors Approves Restructuring of Organization to Lower Operating Expenses >AKLI
Akili Bd of Directors Approves Restructuring of Organization to Lower Operating Expenses >AKLI
Akili Board of Directors Initiates Process to Evaluate Potential Strategic Alternatives to Maximize Shareholder Value >AKLI
Akili Board of Directors Initiates Process to Evaluate Potential Strategic Alternatives to Maximize Shareholder Value >AKLI